G2 Intelligence hosts Lab Institute 2017, the foremost independent national forum for professionals with a stake in the lab industry. This year, the theme “Navigating Uncertainty: From Policy to Patient Care” was sure to bring together experts from government, healthcare, business and academia.
XIFIN was proud to be participating this year as a speaker and the event's hotel keycard and conference lanyard sponsor.
Kyle Fetter, VP & General Manager of Diagnostic Services, XIFIN, Inc. held a panel discussion that addressed the regulatory and compliance issues that regulatory and oversight entities are focusing on in the laboratory and pathology context including the latest developments concerning Laboratory Developed Tests, Direct to Consumer diagnostics, genetic testing and laboratory quality and patient safety.
Laboratory Oversight and Enforcement
Kyle Fetter, VP & General Manager of Diagnostic Services, XIFIN, Inc.
2017 Main Conference Program
Thursday, October 26, 2017
9:15 AM - 10:00 AM
Joyce Gresko, Attorney in Alston & Bird’s Washington, D.C. office, where she is a member of the Health Care and Legislative & Public Policy Teams
G2 Intelligence provides timely, accurate and trusted analysis of industry and market trends, legal and regulatory developments, and technology and innovation that directly affect the operations, financial performance, and competitive position of diagnostic testing laboratories and related medical services providers. The company has covered and reported on the diagnostic industry for over 30 years.